The U.S. Food and Drug Administration and its European counterpart have approved the Eon Mini implantable spinal neurostimulator for the treatment of chronic pain and chronic back pain. The device, which is roughly the size of the U.S. quarter, is rechargeable and is designed to provide 10 years of pain management without removal. The Eon Mini's maker reports that the device's charging system is fully portable, allowing patients the freedom to comfortably recharge the device's battery while...
Read moreReader Question: I am 65 years old. I have been having increased difficulty getting things down from high shelves. I saw my primary... Read more »
One of the most important things you can do for your lower back is keep your core strong and integrated with your spine. I'll explain. ... Read more »
Many of us with chronic pain have noticed that when we get deeply involved in a task that requires concentration, we don't notice our pain... Read more »
Until a cure is found, solutions to help someone live with pain are the next best thing. Complex Regional Pain Syndrome (CRPS) is one such... Read more »
When pain strikes, you may have a hard time deciding what type of health care professional to see. Everyone has an opinion. Grandma says... Read more »
SAN DIEGO (Ivanhoe Broadcast News) -- Richard Eby doesn't let much slow him down. He rollerblades today, but not long ago, Eby was in a wheelchair!... Read more »
Researchers have found that overweight and obese children and teens are more likely to experience severe back pain, abnormalities in their lower... Read more »
A new study in Australia suggests that Lyrica may help ease the pain of patients with spinal-cord injuries. Researchers found that Lyrica was... Read more »
This is a study to evaluate if Lyrica relieves nerve pain associated with spinal cord injury compared to a placebo. The study will also evaluate the... Read more »
Damage to the spinal cord, an information superhighway that originates in the brain, is a very devastating injury that can lead to paralysis. Most... Read more »